Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Zumutor Biologics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Zumutor Biologics

Zumutor Biologics

Zumutor: A leading Immuno-Oncology firm innovating NK cell therapies and novel immunotherapies.

HQ
Bangalore, Karnataka, IN
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Zumutor Biologics, founded in 2015, is a pioneering Immuno-Oncology company specializing in targeted NK cell therapeutics. With a mission to innovate and develop novel immunotherapies, Zumutor leverages two proprietary Antibody Engineering Platforms to enhance innate immunity and regulate the tumor microenvironment. Their flagship platform, INABLR™, generates first-in-class therapeutic antibodies aimed at combating cancer. The company operates from its headquarters at CIC Cambridge Campus in Cambridge, MA, USA, and maintains an ISO-certified laboratory in Bangalore, India.

Notable figures associated with Zumutor include its CEO and founder, Kavitha Iyer Rodrigues. The company has attracted significant investment from prominent venture capital firms such as Bharat Innovation Fund and Accel Partners. Key achievements include the development of multiple first-in-class therapeutic antibodies and securing several patents for their proprietary technologies. Zumutor's impact is evident in its contributions to advancing cancer treatment through innovative NK cell therapies, positioning it as a leader in the Immuno-Oncology space.

Zumutor Biologics - Similar Companies

Meditope Biosciences logo

Meditope Biosciences

meditope.com

INmune Bio logo

INmune Bio

inmunebio.com

Zebra Biologics logo

Zebra Biologics

Inceptor Bio logo

Inceptor Bio

inceptor.bio

Torl Biotherapeutics logo

Torl Biotherapeutics

torlbio.com

Catamaran Bio logo

Catamaran Bio

catamaranbio.com

Numab logo

Numab

numab.com

MonarchBio logo

MonarchBio

monarch-bio.com

LTZ Therapeutics logo

LTZ Therapeutics

BioLoomics logo

BioLoomics

bioloomics.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Bolt Biotherapeutics logo

Bolt Biotherapeutics

boltbio.com

Targazyme logo

Targazyme

targazyme.com

Abintus Bio logo

Abintus Bio

abintusbio.com

Nantkwest logo

Nantkwest

Zumutor Biologics - Quick Facts

Who are Zumutor Biologics' competitors?

Companies similar to Zumutor Biologics include Meditope Biosciences, INmune Bio, Zebra Biologics and Inceptor Bio.

When was Zumutor Biologics founded?

Zumutor Biologics was founded in 2015.

Where is Zumutor Biologics' headquarters located?

Zumutor Biologics' headquarters is located in Bangalore, Karnataka, IN.

When was Zumutor Biologics' last funding round?

Zumutor Biologics' most recent funding round was for $6.2M (USD) in December 2021.

How much has Zumutor Biologics raised to-date?

As of Dec 9, 2021, Zumutor Biologics has raised a total of $41.7M (USD).

How many employees does Zumutor Biologics have?

Zumutor Biologics has 29 employees as of Feb 4, 2024.

Zumutor Biologics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • NK Cell Therapies
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research